- Home
- ATHA vs SAG Comparison
ATHA vs SAG Comparison
Compare ATHA & SAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATHA
- SAG
- Stock Information
- Founded
- ATHA 2011
- SAG 1975
- Country
- ATHA United States
- SAG Singapore
- Employees
- ATHA N/A
- SAG N/A
- Industry
- ATHA Medicinal Chemicals and Botanical Products
- SAG
- Sector
- ATHA Health Care
- SAG
- Exchange
- ATHA Nasdaq
- SAG NYSE
- Market Cap
- ATHA 22.3M
- SAG 26.6M
- IPO Year
- ATHA 2020
- SAG 2024
- Fundamental
- Price
- ATHA $0.54
- SAG $2.72
- Analyst Decision
- ATHA Buy
- SAG
- Analyst Count
- ATHA 4
- SAG 0
- Target Price
- ATHA $11.25
- SAG N/A
- AVG Volume (30 Days)
- ATHA 325.4K
- SAG 186.3K
- Earning Date
- ATHA 11-07-2024
- SAG 12-31-2024
- Dividend Yield
- ATHA N/A
- SAG N/A
- EPS Growth
- ATHA N/A
- SAG 6.90
- EPS
- ATHA N/A
- SAG 0.17
- Revenue
- ATHA N/A
- SAG $59,521,000.00
- Revenue This Year
- ATHA N/A
- SAG N/A
- Revenue Next Year
- ATHA N/A
- SAG N/A
- P/E Ratio
- ATHA N/A
- SAG $15.85
- Revenue Growth
- ATHA N/A
- SAG 15.70
- 52 Week Low
- ATHA $0.41
- SAG $2.25
- 52 Week High
- ATHA $4.30
- SAG $8.27
- Technical
- Relative Strength Index (RSI)
- ATHA 36.91
- SAG N/A
- Support Level
- ATHA $0.56
- SAG N/A
- Resistance Level
- ATHA $0.61
- SAG N/A
- Average True Range (ATR)
- ATHA 0.04
- SAG 0.00
- MACD
- ATHA -0.01
- SAG 0.00
- Stochastic Oscillator
- ATHA 8.45
- SAG 0.00
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) a subcutaneously administered, small molecule positive modulator of the HGF/MET system for CNS disorders, ATH-1020 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system. ATH-1105 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system, and several other compounds in preclinical discovery and development for neurodegenerative diseases, including ATH-1018 and ATH-1019.
About SAG SAG HOLDINGS LTD
SAG Holdings Ltd engages in the business of distributing automotive and industrial spare parts with operations primarily based in Singapore, and global sales primarily generated from the Middle East and Malaysia. Its business is comprised of On-Highway Business serving the automotive sector and Off-Highway Business primarily servicing the marine, energy, mining, construction, agriculture, and oil and gas sectors. The On-Highway Business Segment supply genuine and aftermarket spare parts to customers through our Autozone retail outlets located in Singapore, as well as Malaysia. The Off-Highway Business Segment supply a wide range of components and spare parts for internal combustion engines with a strong focus on filtration products through Filtec.